1. Home
  2. NTCT vs STOK Comparison

NTCT vs STOK Comparison

Compare NTCT & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetScout Systems Inc.

NTCT

NetScout Systems Inc.

HOLD

Current Price

$29.59

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$31.75

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTCT
STOK
Founded
1984
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
1999
2019

Fundamental Metrics

Financial Performance
Metric
NTCT
STOK
Price
$29.59
$31.75
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$31.00
$34.50
AVG Volume (30 Days)
486.9K
592.7K
Earning Date
02-05-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.32
0.68
Revenue
$861,434,000.00
$205,632,000.00
Revenue This Year
$5.90
$428.87
Revenue Next Year
$2.62
N/A
P/E Ratio
$22.49
$46.60
Revenue Growth
4.91
1128.17
52 Week Low
$18.12
$5.35
52 Week High
$30.67
$38.69

Technical Indicators

Market Signals
Indicator
NTCT
STOK
Relative Strength Index (RSI) 64.53 52.53
Support Level $27.80 $30.75
Resistance Level $28.72 $33.28
Average True Range (ATR) 0.99 2.13
MACD 0.13 0.16
Stochastic Oscillator 98.91 52.59

Price Performance

Historical Comparison
NTCT
STOK

About NTCT NetScout Systems Inc.

NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: